APA

Mahdi H., Rose P. G., Elshaikh M. A., Munkarah A., Isrow D., Singh S., Waggoner S., Ali-Fehmi R., Morris R. T., Harding J. & DeBenardo R. (20150609). Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study. : Gynecologic oncology.

Chicago

Mahdi Haider, Rose Peter G, Elshaikh Mohammed A, Munkarah Adnan, Isrow Derek, Singh Sareena, Waggoner Steven, Ali-Fehmi Rouba, Morris Robort T, Harding Jarod and DeBenardo Robert. 20150609. Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study. : Gynecologic oncology.

Harvard

Mahdi H., Rose P. G., Elshaikh M. A., Munkarah A., Isrow D., Singh S., Waggoner S., Ali-Fehmi R., Morris R. T., Harding J. and DeBenardo R. (20150609). Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study. : Gynecologic oncology.

MLA

Mahdi Haider, Rose Peter G, Elshaikh Mohammed A, Munkarah Adnan, Isrow Derek, Singh Sareena, Waggoner Steven, Ali-Fehmi Rouba, Morris Robort T, Harding Jarod and DeBenardo Robert. Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study. : Gynecologic oncology. 20150609.